Pfizer (PFE) Q3 2022 Earnings Call Transcript

PFE earnings call for the period ending September 30, 2022.

Related Keywords

New York ,United States ,United Arab Emirates ,Israel ,Kuwait ,Robyn Karnauskas ,David Risinger ,Andrew Baum ,Albert Bourla ,Tim Anderson ,Chris Stevo ,Evan Seigerman ,Chris Shibutani ,Terence Flynn Morgan Stanley ,William Pao ,Dave Denton ,Angela Hwang ,Doug Lankler ,Louise Chen Cantor Fitzgerald ,Terence Flynn ,Andrew Baum Citi ,Geoff Meacham ,Steve Scala Cowen ,Steve Scala ,America Merrill Lynch ,Chris Schott Jpmorgan ,Aamir Malik ,Robyn Karnauskas Truist ,Mikael Dolsten ,Louise Chen ,Chris Schott ,Chris Shibutani Goldman Sachs ,Colin Bristow ,Mohit Bansal ,Morgan Stanley ,Accor ,Goldman Sachs ,Geoff Meacham Bank ,Brian Tsang Wolfe Research Analyst ,Worldwide Research ,Pfizer ,Global Fund ,European Union ,Wolfe Research ,Company Analyst ,Wells Fargo ,Biohaven Pharmaceuticals ,Drug Administration ,Data Monitoring Committee ,European Medicines Agency ,Vice President ,Chief Investor Relations ,Analyst Day ,New York City ,Investor Relations ,Risk Factors ,Forward Looking Information ,Factors That May Affect Future ,Chief Executive ,Global Blood Therapeutics ,Umer Raffat ,Global Blood ,Chief Development ,Fargo Securities ,Truist Securities ,Executive Vice President ,Wells Fargo Securities ,